Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2,181,288,547
-
Number of holders
-
1,115
-
Total 13F shares, excl. options
-
216,752,152
-
Shares change
-
-1,169,354
-
Total reported value, excl. options
-
$19,776,538,734
-
Value change
-
-$101,066,270
-
Put/Call ratio
-
34%
-
Number of buys
-
456
-
Number of sells
-
-490
-
Price
-
$91.24
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q2 2021
1,217 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q2 2021.
NOVARTIS AG - Ordinary Shares (NVS) has 1,115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 216,752,152 shares
of 2,181,288,547 outstanding shares and own 9.94% of the company stock.
Largest 10 shareholders include Dodge & Cox (24,453,265 shares), PRIMECAP MANAGEMENT CO/CA/ (19,281,850 shares), LOOMIS SAYLES & CO L P (19,019,589 shares), Fisher Asset Management, LLC (9,962,426 shares), BANK OF AMERICA CORP /DE/ (9,001,642 shares), Aristotle Capital Management, LLC (8,066,097 shares), FRANKLIN RESOURCES INC (7,522,188 shares), Boston Partners (6,299,760 shares), WELLS FARGO & COMPANY/MN (5,395,833 shares), and UBS Group AG (4,759,736 shares).
This table shows the top 1115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.